MEK inhibitors block AICAR‐induced maturation in mouse oocytes by a MAPK‐independent mechanism
- 29 November 2004
- journal article
- research article
- Published by Wiley in Molecular Reproduction and Development
- Vol. 70 (2) , 235-245
- https://doi.org/10.1002/mrd.20200
Abstract
The present study was carried out to assess the possible role of mitogen‐activated protein kinase (MAPK) in the meiosis‐inducing action of the AMP‐activated protein kinase (AMPK) activator, 5‐aminoimidazole‐4‐carboxamide 1‐β‐ribofuranoside (AICAR). Cumulus cell‐enclosed oocytes (CEO) or denuded oocytes (DO) from immature, eCG‐primed mice were cultured 4 hr in Eagle's minimum essential medium containing dbcAMP plus increasing concentrations of AICAR or okadaic acid (OA). OA is a phosphatase inhibitor known to stimulate both meiotic maturation and MAPK activation and served as a positive control. Both OA and AICAR were potent inducers of meiotic resumption in mouse oocytes and brought about the phosphorylation (and thus, activation) of MAPK, but by different kinetics: MAPK phosphorylation preceded GVB in OA‐treated oocytes, while that resulting from AICAR treatment appeared only after GVB. The MEK inhibitors, PD98059 and U0126, blocked the meiotic resumption induced by AICAR but not that induced by OA. Although the MEK inhibitors suppressed MAPK phosphorylation in both OA‐ and AICAR‐treated oocytes, meiotic resumption was not causally linked to MAPK phosphorylation in either group. Furthermore, AICAR‐induced meiotic resumption in Mos‐null oocytes (which are unable to stimulate MAPK) was also abrogated by PD98059 treatment. A non‐specific effect of the MEK inhibitors on AICAR accessibility to the oocyte was discounted by showing that they failed to suppress either nucleoside uptake or AICAR‐stimulated phosphorylation of acetyl CoA carboxylase (ACC), a substrate of AMPK. The suppression of AICAR‐induced maturation by MEK inhibitors must, therefore, be occurring by actions unrelated to MEK stimulation of MAPK; consequently, it would be prudent to consider this possible non‐specific action of the inhibitors when they are used to block MAPK activation in mouse oocytes. Mol. Reprod. Dev. 70: 235–245, 2005.Keywords
This publication has 82 references indexed in Scilit:
- Specificity of the Cyclic Adenosine 3′,5′-Monophosphate Signal in Granulosa Cell FunctionBiology of Reproduction, 2002
- Chromosome condensation in pig oocytes: Lack of a requirement for either cdc2 kinase or MAP kinase activityMolecular Reproduction and Development, 2002
- Regulation of Translation During In Vitro Maturation of Bovine Oocytes: The Role of MAP Kinase, eIF4E (Cap Binding Protein) Phosphorylation, and eIF4E-BP11Biology of Reproduction, 2002
- Inactivation of Ca2+ Action Potential Channels by the MEK Inhibitor PD98059Experimental Cell Research, 2000
- MPF Amplification inXenopusOocyte Extracts Depends on a Two-Step Activation of Cdc25 PhosphataseExperimental Cell Research, 1998
- Effects of follicle-stimulating hormone, bovine somototrophin and okadaic acid on cumulus expansion and nuclear maturation of Blue fox (Alopex lagopus) oocytes in vitroZygote, 1998
- Induction of M-phase entry of prophase-blocked mouse oocytes through microinjection of okadaic acid, a specific phosphatase inhibitorExperimental Cell Research, 1991
- Protein phosphatases are involved in the in vivo activation of histone H1 kinase in mouse oocyteDevelopmental Biology, 1990
- Control of M-phase by maturation-promoting factorCurrent Opinion in Cell Biology, 1990
- Universal control mechanism regulating onset of M-phaseNature, 1990